Home
Logos Global Management reported a 4.4% stake in Design Therapeutics DSGN · 2,515,000 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 4.4%
- Last report
- 5.7% · filed 25/11/12
- Shares held
- 2,515,000 sh
- Class
- Common Stock
- Holder
- Logos Global Management
- Event date
- 25/11/14
- Filed
- 25/11/18
4.4% stake · below 5%
- Stake
- 4.4%
- Last report
- 5.7%
- Since last report
- −1.3pp
Design Therapeutics trades, last 26 weeks
What else happened in Design Therapeutics around then
Filed or reported within 30 days of the trade day · 25/10/15~25/12/14Logos Global Management's other 5% stake reports
- Logos Global Management
5% stakeLongeveron
5% stakeLongeveron
LGVN
6.3% stake
192,308 sh
6.3% stake
Filed 09/10
- Logos Global Management
5% stakeAchieve Life Sciences
5% stakeAchieve Life Sciences
ACHV
9.99% stake
10,538,440 sh
9.99% stake
Filed 08/17
- Logos Global Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
9.9% stake
276,704 sh
9.9% stake
Filed 08/04
- Logos Global Management
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
3% stake
800,000 sh
3% stake
Filed 05/15
- Logos Global Management
5% stakeiBio
5% stakeiBio
IBIO
0% stake
0 sh
0% stake
Filed 05/15
